俞募配穴埋线治疗慢性放射性肠炎的临床效果
2019-04-21杨杨
杨杨



【摘要】 目的:探讨俞募配穴埋线治疗慢性放射性肠炎的临床效果。方法:选取笔者所在医院2017年1月-2018年6月收治的慢性放射性肠炎患者80例,随机分为对照组、观察组,各40例。对照组采用常规西药治疗,观察组在对照组基础上采用俞募配穴埋线治疗。比较两组治疗前后大便次数、便血情况、大便正常情况及临床疗效。结果:治疗后,对照组大便次数及便血均多于观察组(P<0.05)。观察组治疗后大便改善情况优于对照组(P<0.05)。对照组治疗总有效率低于观察组(P<0.05)。结论:俞募配穴埋线治疗慢性放射性肠炎效果十分理想,患者临床症状改善明显,治疗总有效率较高,临床上值得推广使用。
【关键词】 俞募配穴 放射性肠炎 埋线治疗 效果
doi:10.14033/j.cnki.cfmr.2019.30.023 文献标识码 B 文章编号 1674-6805(2019)30-00-03
[Abstract] Objective: To explore the effect of Back-Shu and Front-Mu acupoints embedding treatment in the treatment of chronic radioactive enteritis. Method: A total of 80 cases of chronic radioactive enteritis admitted to our hospital from January 2017 to June 2018 were randomly divided into the control group and the observation group, with 40 cases in each groups. The control group was treated with conventional western medicine, while the observation group was treated with the Back-Shu and Front-Mu acupoints embedding treatment on the basis of the control group. The frequency of stools, hematochezia, normal stools and clinical efficacy before and after treatment were compared between the two groups. Result: After treatment, the frequency of stools and hematochezia in the control group were more than those of the observation group (P<0.05). After treatment, the improvement of stool in the observation group was better than that of the control group (P<0.05). And the total effective rate of the control group was lower than that of the observation group (P<0.05). Conclusion: The effect of Back-Shu and Front-Mu acupoints embedding treatment in the treatment of chronic radioactive enteritis is very ideal, the clinical symptoms of the patients are improved significantly, the total effective rate of treatment is higher, and it is worth promoting for clinical application.
[Key words] Back-Shu and Front-Mu acupoints Radioactive enteritis Embedding therapy Effect
First-authors address: The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530022, China
放射性腸炎常见于盆腔、腹腔等恶性肿瘤行放疗治疗的患者,为放疗后常见的并发症,可累及小肠、结肠及直肠,又称为放射性小肠、结肠、直肠炎[1]。根据恶性肿瘤患者接受放疗治疗的不同剂量、不同时间,可分为急性及慢性两种。慢性放射性肠炎患者发病初期常伴随胃肠道反应,后期可伴随盆腔脓肿、便血、乏力等症状,严重影响患者生活质量,威胁生命健康安全[2]。临床上针对慢性放射性肠炎患者常采用药物进行控制治疗,常规采用抗生素给予抗感染治疗,针对出现里急后重的患者进行保留灌肠治疗[3]。本文针对俞募配穴埋线治疗慢性放射性肠炎的效果进行探讨分析,具体如下。
1 资料与方法
1.1 一般资料
选取的80例慢性放射性肠炎患者均为笔者所在医院于2017年1月-2018年6月收治。慢性放射性肠炎诊断标准:盆腔、腹腔、腹膜后恶性肿瘤经放射治疗致使小肠、直肠、结肠黏膜损伤,临床表现为恶心呕吐、大便排不尽且变细、大便频繁、便血、溃疡等[4]。……
